Global Equine Chorionic Gonadotropin (eCG) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Equine Chorionic Gonadotropin (eCG) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
The Global Info Research report includes an overview of the development of the Equine Chorionic Gonadotropin (eCG) industry chain, the market status of Infertility Treatment (Lyophilized Powder, Liquid Form), Reproduction Assistance (Lyophilized Powder, Liquid Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Equine Chorionic Gonadotropin (eCG).
Regionally, the report analyzes the Equine Chorionic Gonadotropin (eCG) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Equine Chorionic Gonadotropin (eCG) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Equine Chorionic Gonadotropin (eCG) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Equine Chorionic Gonadotropin (eCG) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M IU), revenue generated, and market share of different by Type (e.g., Lyophilized Powder, Liquid Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Equine Chorionic Gonadotropin (eCG) market.
Regional Analysis: The report involves examining the Equine Chorionic Gonadotropin (eCG) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Equine Chorionic Gonadotropin (eCG) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Equine Chorionic Gonadotropin (eCG):
Company Analysis: Report covers individual Equine Chorionic Gonadotropin (eCG) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Equine Chorionic Gonadotropin (eCG) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infertility Treatment, Reproduction Assistance).
Technology Analysis: Report covers specific technologies relevant to Equine Chorionic Gonadotropin (eCG). It assesses the current state, advancements, and potential future developments in Equine Chorionic Gonadotropin (eCG) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Equine Chorionic Gonadotropin (eCG) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Equine Chorionic Gonadotropin (eCG) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Equine Chorionic Gonadotropin (eCG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Chorionic Gonadotropin (eCG), with price, sales, revenue and global market share of Equine Chorionic Gonadotropin (eCG) from 2019 to 2024.
Chapter 3, the Equine Chorionic Gonadotropin (eCG) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Chorionic Gonadotropin (eCG) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Equine Chorionic Gonadotropin (eCG) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Chorionic Gonadotropin (eCG).
Chapter 14 and 15, to describe Equine Chorionic Gonadotropin (eCG) sales channel, distributors, customers, research findings and conclusion.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
The Global Info Research report includes an overview of the development of the Equine Chorionic Gonadotropin (eCG) industry chain, the market status of Infertility Treatment (Lyophilized Powder, Liquid Form), Reproduction Assistance (Lyophilized Powder, Liquid Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Equine Chorionic Gonadotropin (eCG).
Regionally, the report analyzes the Equine Chorionic Gonadotropin (eCG) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Equine Chorionic Gonadotropin (eCG) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Equine Chorionic Gonadotropin (eCG) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Equine Chorionic Gonadotropin (eCG) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M IU), revenue generated, and market share of different by Type (e.g., Lyophilized Powder, Liquid Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Equine Chorionic Gonadotropin (eCG) market.
Regional Analysis: The report involves examining the Equine Chorionic Gonadotropin (eCG) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Equine Chorionic Gonadotropin (eCG) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Equine Chorionic Gonadotropin (eCG):
Company Analysis: Report covers individual Equine Chorionic Gonadotropin (eCG) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Equine Chorionic Gonadotropin (eCG) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infertility Treatment, Reproduction Assistance).
Technology Analysis: Report covers specific technologies relevant to Equine Chorionic Gonadotropin (eCG). It assesses the current state, advancements, and potential future developments in Equine Chorionic Gonadotropin (eCG) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Equine Chorionic Gonadotropin (eCG) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Equine Chorionic Gonadotropin (eCG) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Lyophilized Powder
- Liquid Form
- Infertility Treatment
- Reproduction Assistance
- MSD Animal Health
- Phiphar Healthcare Limited
- RayBiotech
- Ceva Santй Animale
- Antech
- Gansu Tianqi Biological Technology
- Xiamen Origin Biotech
- Cixi No.2 Hormones Factory
- Biorigin (Beijing) Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Equine Chorionic Gonadotropin (eCG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Chorionic Gonadotropin (eCG), with price, sales, revenue and global market share of Equine Chorionic Gonadotropin (eCG) from 2019 to 2024.
Chapter 3, the Equine Chorionic Gonadotropin (eCG) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Chorionic Gonadotropin (eCG) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Equine Chorionic Gonadotropin (eCG) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Chorionic Gonadotropin (eCG).
Chapter 14 and 15, to describe Equine Chorionic Gonadotropin (eCG) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Equine Chorionic Gonadotropin (eCG)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Lyophilized Powder
1.3.3 Liquid Form
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infertility Treatment
1.4.3 Reproduction Assistance
1.5 Global Equine Chorionic Gonadotropin (eCG) Market Size & Forecast
1.5.1 Global Equine Chorionic Gonadotropin (eCG) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity (2019-2030)
1.5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 MSD Animal Health
2.1.1 MSD Animal Health Details
2.1.2 MSD Animal Health Major Business
2.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product and Services
2.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 MSD Animal Health Recent Developments/Updates
2.2 Phiphar Healthcare Limited
2.2.1 Phiphar Healthcare Limited Details
2.2.2 Phiphar Healthcare Limited Major Business
2.2.3 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product and Services
2.2.4 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Phiphar Healthcare Limited Recent Developments/Updates
2.3 RayBiotech
2.3.1 RayBiotech Details
2.3.2 RayBiotech Major Business
2.3.3 RayBiotech Equine Chorionic Gonadotropin (eCG) Product and Services
2.3.4 RayBiotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 RayBiotech Recent Developments/Updates
2.4 Ceva Santй Animale
2.4.1 Ceva Santй Animale Details
2.4.2 Ceva Santй Animale Major Business
2.4.3 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Product and Services
2.4.4 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Ceva Santй Animale Recent Developments/Updates
2.5 Antech
2.5.1 Antech Details
2.5.2 Antech Major Business
2.5.3 Antech Equine Chorionic Gonadotropin (eCG) Product and Services
2.5.4 Antech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Antech Recent Developments/Updates
2.6 Gansu Tianqi Biological Technology
2.6.1 Gansu Tianqi Biological Technology Details
2.6.2 Gansu Tianqi Biological Technology Major Business
2.6.3 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product and Services
2.6.4 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gansu Tianqi Biological Technology Recent Developments/Updates
2.7 Xiamen Origin Biotech
2.7.1 Xiamen Origin Biotech Details
2.7.2 Xiamen Origin Biotech Major Business
2.7.3 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product and Services
2.7.4 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Xiamen Origin Biotech Recent Developments/Updates
2.8 Cixi No.2 Hormones Factory
2.8.1 Cixi No.2 Hormones Factory Details
2.8.2 Cixi No.2 Hormones Factory Major Business
2.8.3 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product and Services
2.8.4 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cixi No.2 Hormones Factory Recent Developments/Updates
2.9 Biorigin (Beijing) Inc.
2.9.1 Biorigin (Beijing) Inc. Details
2.9.2 Biorigin (Beijing) Inc. Major Business
2.9.3 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product and Services
2.9.4 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biorigin (Beijing) Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EQUINE CHORIONIC GONADOTROPIN (ECG) BY MANUFACTURER
3.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Manufacturer (2019-2024)
3.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Equine Chorionic Gonadotropin (eCG) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
3.4.2 Top 6 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
3.5 Equine Chorionic Gonadotropin (eCG) Market: Overall Company Footprint Analysis
3.5.1 Equine Chorionic Gonadotropin (eCG) Market: Region Footprint
3.5.2 Equine Chorionic Gonadotropin (eCG) Market: Company Product Type Footprint
3.5.3 Equine Chorionic Gonadotropin (eCG) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Equine Chorionic Gonadotropin (eCG) Market Size by Region
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2019-2030)
4.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.3 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.4 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.5 South America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.6 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
5.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2019-2030)
5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
6.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2019-2030)
6.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
7.2 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
7.3 North America Equine Chorionic Gonadotropin (eCG) Market Size by Country
7.3.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
7.3.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
8.2 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
8.3 Europe Equine Chorionic Gonadotropin (eCG) Market Size by Country
8.3.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
8.3.2 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Market Size by Region
9.3.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
10.2 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
10.3 South America Equine Chorionic Gonadotropin (eCG) Market Size by Country
10.3.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
10.3.2 South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Market Size by Country
11.3.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Equine Chorionic Gonadotropin (eCG) Market Drivers
12.2 Equine Chorionic Gonadotropin (eCG) Market Restraints
12.3 Equine Chorionic Gonadotropin (eCG) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Equine Chorionic Gonadotropin (eCG) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Chorionic Gonadotropin (eCG)
13.3 Equine Chorionic Gonadotropin (eCG) Production Process
13.4 Equine Chorionic Gonadotropin (eCG) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Chorionic Gonadotropin (eCG) Typical Distributors
14.3 Equine Chorionic Gonadotropin (eCG) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Equine Chorionic Gonadotropin (eCG)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Lyophilized Powder
1.3.3 Liquid Form
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infertility Treatment
1.4.3 Reproduction Assistance
1.5 Global Equine Chorionic Gonadotropin (eCG) Market Size & Forecast
1.5.1 Global Equine Chorionic Gonadotropin (eCG) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity (2019-2030)
1.5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 MSD Animal Health
2.1.1 MSD Animal Health Details
2.1.2 MSD Animal Health Major Business
2.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product and Services
2.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 MSD Animal Health Recent Developments/Updates
2.2 Phiphar Healthcare Limited
2.2.1 Phiphar Healthcare Limited Details
2.2.2 Phiphar Healthcare Limited Major Business
2.2.3 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product and Services
2.2.4 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Phiphar Healthcare Limited Recent Developments/Updates
2.3 RayBiotech
2.3.1 RayBiotech Details
2.3.2 RayBiotech Major Business
2.3.3 RayBiotech Equine Chorionic Gonadotropin (eCG) Product and Services
2.3.4 RayBiotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 RayBiotech Recent Developments/Updates
2.4 Ceva Santй Animale
2.4.1 Ceva Santй Animale Details
2.4.2 Ceva Santй Animale Major Business
2.4.3 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Product and Services
2.4.4 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Ceva Santй Animale Recent Developments/Updates
2.5 Antech
2.5.1 Antech Details
2.5.2 Antech Major Business
2.5.3 Antech Equine Chorionic Gonadotropin (eCG) Product and Services
2.5.4 Antech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Antech Recent Developments/Updates
2.6 Gansu Tianqi Biological Technology
2.6.1 Gansu Tianqi Biological Technology Details
2.6.2 Gansu Tianqi Biological Technology Major Business
2.6.3 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product and Services
2.6.4 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gansu Tianqi Biological Technology Recent Developments/Updates
2.7 Xiamen Origin Biotech
2.7.1 Xiamen Origin Biotech Details
2.7.2 Xiamen Origin Biotech Major Business
2.7.3 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product and Services
2.7.4 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Xiamen Origin Biotech Recent Developments/Updates
2.8 Cixi No.2 Hormones Factory
2.8.1 Cixi No.2 Hormones Factory Details
2.8.2 Cixi No.2 Hormones Factory Major Business
2.8.3 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product and Services
2.8.4 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cixi No.2 Hormones Factory Recent Developments/Updates
2.9 Biorigin (Beijing) Inc.
2.9.1 Biorigin (Beijing) Inc. Details
2.9.2 Biorigin (Beijing) Inc. Major Business
2.9.3 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product and Services
2.9.4 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biorigin (Beijing) Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EQUINE CHORIONIC GONADOTROPIN (ECG) BY MANUFACTURER
3.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Manufacturer (2019-2024)
3.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Equine Chorionic Gonadotropin (eCG) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
3.4.2 Top 6 Equine Chorionic Gonadotropin (eCG) Manufacturer Market Share in 2023
3.5 Equine Chorionic Gonadotropin (eCG) Market: Overall Company Footprint Analysis
3.5.1 Equine Chorionic Gonadotropin (eCG) Market: Region Footprint
3.5.2 Equine Chorionic Gonadotropin (eCG) Market: Company Product Type Footprint
3.5.3 Equine Chorionic Gonadotropin (eCG) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Equine Chorionic Gonadotropin (eCG) Market Size by Region
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2019-2030)
4.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.3 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.4 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.5 South America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
4.6 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
5.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2019-2030)
5.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
6.2 Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2019-2030)
6.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
7.2 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
7.3 North America Equine Chorionic Gonadotropin (eCG) Market Size by Country
7.3.1 North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
7.3.2 North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
8.2 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
8.3 Europe Equine Chorionic Gonadotropin (eCG) Market Size by Country
8.3.1 Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
8.3.2 Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Market Size by Region
9.3.1 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
10.2 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
10.3 South America Equine Chorionic Gonadotropin (eCG) Market Size by Country
10.3.1 South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
10.3.2 South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Market Size by Country
11.3.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Equine Chorionic Gonadotropin (eCG) Market Drivers
12.2 Equine Chorionic Gonadotropin (eCG) Market Restraints
12.3 Equine Chorionic Gonadotropin (eCG) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Equine Chorionic Gonadotropin (eCG) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Chorionic Gonadotropin (eCG)
13.3 Equine Chorionic Gonadotropin (eCG) Production Process
13.4 Equine Chorionic Gonadotropin (eCG) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Chorionic Gonadotropin (eCG) Typical Distributors
14.3 Equine Chorionic Gonadotropin (eCG) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. MSD Animal Health Major Business
Table 5. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product and Services
Table 6. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. MSD Animal Health Recent Developments/Updates
Table 8. Phiphar Healthcare Limited Basic Information, Manufacturing Base and Competitors
Table 9. Phiphar Healthcare Limited Major Business
Table 10. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product and Services
Table 11. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Phiphar Healthcare Limited Recent Developments/Updates
Table 13. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 14. RayBiotech Major Business
Table 15. RayBiotech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 16. RayBiotech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. RayBiotech Recent Developments/Updates
Table 18. Ceva Santй Animale Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Santй Animale Major Business
Table 20. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Product and Services
Table 21. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Ceva Santй Animale Recent Developments/Updates
Table 23. Antech Basic Information, Manufacturing Base and Competitors
Table 24. Antech Major Business
Table 25. Antech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 26. Antech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Antech Recent Developments/Updates
Table 28. Gansu Tianqi Biological Technology Basic Information, Manufacturing Base and Competitors
Table 29. Gansu Tianqi Biological Technology Major Business
Table 30. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product and Services
Table 31. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gansu Tianqi Biological Technology Recent Developments/Updates
Table 33. Xiamen Origin Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Xiamen Origin Biotech Major Business
Table 35. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 36. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Xiamen Origin Biotech Recent Developments/Updates
Table 38. Cixi No.2 Hormones Factory Basic Information, Manufacturing Base and Competitors
Table 39. Cixi No.2 Hormones Factory Major Business
Table 40. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product and Services
Table 41. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Cixi No.2 Hormones Factory Recent Developments/Updates
Table 43. Biorigin (Beijing) Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Biorigin (Beijing) Inc. Major Business
Table 45. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product and Services
Table 46. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Biorigin (Beijing) Inc. Recent Developments/Updates
Table 48. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Manufacturer (2019-2024) & (M IU)
Table 49. Global Equine Chorionic Gonadotropin (eCG) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturer (2019-2024) & (US$/IU)
Table 51. Market Position of Manufacturers in Equine Chorionic Gonadotropin (eCG), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Equine Chorionic Gonadotropin (eCG) Production Site of Key Manufacturer
Table 53. Equine Chorionic Gonadotropin (eCG) Market: Company Product Type Footprint
Table 54. Equine Chorionic Gonadotropin (eCG) Market: Company Product Application Footprint
Table 55. Equine Chorionic Gonadotropin (eCG) New Market Entrants and Barriers to Market Entry
Table 56. Equine Chorionic Gonadotropin (eCG) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 58. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 59. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2019-2024) & (US$/IU)
Table 62. Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2025-2030) & (US$/IU)
Table 63. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 64. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 65. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2024) & (US$/IU)
Table 68. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2025-2030) & (US$/IU)
Table 69. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 70. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 71. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2024) & (US$/IU)
Table 74. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2025-2030) & (US$/IU)
Table 75. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 76. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 77. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 78. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 79. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 80. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 81. North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 84. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 85. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 86. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 87. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 88. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 89. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 92. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 93. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 94. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 95. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 96. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 97. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 100. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 101. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 102. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 103. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 104. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 105. South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 108. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 109. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 110. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 111. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 112. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 113. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Equine Chorionic Gonadotropin (eCG) Raw Material
Table 116. Key Manufacturers of Equine Chorionic Gonadotropin (eCG) Raw Materials
Table 117. Equine Chorionic Gonadotropin (eCG) Typical Distributors
Table 118. Equine Chorionic Gonadotropin (eCG) Typical Customers
LIST OF FIGURE
s
Figure 1. Equine Chorionic Gonadotropin (eCG) Picture
Figure 2. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Type in 2023
Figure 4. Lyophilized Powder Examples
Figure 5. Liquid Form Examples
Figure 6. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Application in 2023
Figure 8. Infertility Treatment Examples
Figure 9. Reproduction Assistance Examples
Figure 10. Global Equine Chorionic Gonadotropin (eCG) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Equine Chorionic Gonadotropin (eCG) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity (2019-2030) & (M IU)
Figure 13. Global Equine Chorionic Gonadotropin (eCG) Average Price (2019-2030) & (US$/IU)
Figure 14. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Equine Chorionic Gonadotropin (eCG) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Equine Chorionic Gonadotropin (eCG) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Equine Chorionic Gonadotropin (eCG) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2030) & (US$/IU)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2030) & (US$/IU)
Figure 32. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Equine Chorionic Gonadotropin (eCG) Market Drivers
Figure 73. Equine Chorionic Gonadotropin (eCG) Market Restraints
Figure 74. Equine Chorionic Gonadotropin (eCG) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) in 2023
Figure 77. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
Figure 78. Equine Chorionic Gonadotropin (eCG) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Table 1. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. MSD Animal Health Major Business
Table 5. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product and Services
Table 6. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. MSD Animal Health Recent Developments/Updates
Table 8. Phiphar Healthcare Limited Basic Information, Manufacturing Base and Competitors
Table 9. Phiphar Healthcare Limited Major Business
Table 10. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product and Services
Table 11. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Phiphar Healthcare Limited Recent Developments/Updates
Table 13. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 14. RayBiotech Major Business
Table 15. RayBiotech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 16. RayBiotech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. RayBiotech Recent Developments/Updates
Table 18. Ceva Santй Animale Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Santй Animale Major Business
Table 20. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Product and Services
Table 21. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Ceva Santй Animale Recent Developments/Updates
Table 23. Antech Basic Information, Manufacturing Base and Competitors
Table 24. Antech Major Business
Table 25. Antech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 26. Antech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Antech Recent Developments/Updates
Table 28. Gansu Tianqi Biological Technology Basic Information, Manufacturing Base and Competitors
Table 29. Gansu Tianqi Biological Technology Major Business
Table 30. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product and Services
Table 31. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gansu Tianqi Biological Technology Recent Developments/Updates
Table 33. Xiamen Origin Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Xiamen Origin Biotech Major Business
Table 35. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product and Services
Table 36. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Xiamen Origin Biotech Recent Developments/Updates
Table 38. Cixi No.2 Hormones Factory Basic Information, Manufacturing Base and Competitors
Table 39. Cixi No.2 Hormones Factory Major Business
Table 40. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product and Services
Table 41. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Cixi No.2 Hormones Factory Recent Developments/Updates
Table 43. Biorigin (Beijing) Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Biorigin (Beijing) Inc. Major Business
Table 45. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product and Services
Table 46. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales Quantity (M IU), Average Price (US$/IU), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Biorigin (Beijing) Inc. Recent Developments/Updates
Table 48. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Manufacturer (2019-2024) & (M IU)
Table 49. Global Equine Chorionic Gonadotropin (eCG) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturer (2019-2024) & (US$/IU)
Table 51. Market Position of Manufacturers in Equine Chorionic Gonadotropin (eCG), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Equine Chorionic Gonadotropin (eCG) Production Site of Key Manufacturer
Table 53. Equine Chorionic Gonadotropin (eCG) Market: Company Product Type Footprint
Table 54. Equine Chorionic Gonadotropin (eCG) Market: Company Product Application Footprint
Table 55. Equine Chorionic Gonadotropin (eCG) New Market Entrants and Barriers to Market Entry
Table 56. Equine Chorionic Gonadotropin (eCG) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 58. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 59. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2019-2024) & (US$/IU)
Table 62. Global Equine Chorionic Gonadotropin (eCG) Average Price by Region (2025-2030) & (US$/IU)
Table 63. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 64. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 65. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2024) & (US$/IU)
Table 68. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2025-2030) & (US$/IU)
Table 69. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 70. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 71. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2024) & (US$/IU)
Table 74. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2025-2030) & (US$/IU)
Table 75. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 76. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 77. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 78. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 79. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 80. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 81. North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 84. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 85. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 86. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 87. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 88. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 89. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 92. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 93. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 94. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 95. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 96. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 97. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 100. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 101. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 102. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 103. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2019-2024) & (M IU)
Table 104. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity by Country (2025-2030) & (M IU)
Table 105. South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Equine Chorionic Gonadotropin (eCG) Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2019-2024) & (M IU)
Table 108. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Type (2025-2030) & (M IU)
Table 109. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2019-2024) & (M IU)
Table 110. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Application (2025-2030) & (M IU)
Table 111. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2019-2024) & (M IU)
Table 112. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity by Region (2025-2030) & (M IU)
Table 113. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Equine Chorionic Gonadotropin (eCG) Raw Material
Table 116. Key Manufacturers of Equine Chorionic Gonadotropin (eCG) Raw Materials
Table 117. Equine Chorionic Gonadotropin (eCG) Typical Distributors
Table 118. Equine Chorionic Gonadotropin (eCG) Typical Customers
LIST OF FIGURE
s
Figure 1. Equine Chorionic Gonadotropin (eCG) Picture
Figure 2. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Type in 2023
Figure 4. Lyophilized Powder Examples
Figure 5. Liquid Form Examples
Figure 6. Global Equine Chorionic Gonadotropin (eCG) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Application in 2023
Figure 8. Infertility Treatment Examples
Figure 9. Reproduction Assistance Examples
Figure 10. Global Equine Chorionic Gonadotropin (eCG) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Equine Chorionic Gonadotropin (eCG) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity (2019-2030) & (M IU)
Figure 13. Global Equine Chorionic Gonadotropin (eCG) Average Price (2019-2030) & (US$/IU)
Figure 14. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Equine Chorionic Gonadotropin (eCG) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Equine Chorionic Gonadotropin (eCG) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Equine Chorionic Gonadotropin (eCG) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Equine Chorionic Gonadotropin (eCG) Average Price by Type (2019-2030) & (US$/IU)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) Average Price by Application (2019-2030) & (US$/IU)
Figure 32. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Equine Chorionic Gonadotropin (eCG) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Equine Chorionic Gonadotropin (eCG) Market Drivers
Figure 73. Equine Chorionic Gonadotropin (eCG) Market Restraints
Figure 74. Equine Chorionic Gonadotropin (eCG) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) in 2023
Figure 77. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG)
Figure 78. Equine Chorionic Gonadotropin (eCG) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
